Key points are not available for this paper at this time.
In typical pharmacoepidemiologic studies, the proposed high-dimensional propensity score resulted in improved effect estimates compared with adjustment limited to predefined covariates, when benchmarked against results expected from randomized trials.
Schneeweiß et al. (2009) studied this question.